Companies including Dr Reddy’s will consider investing in new API units if the Indian government tweaks its incentive scheme to permit exports of surplus production. Other suggested changes to the $1.3bn stimulus, aimed at enhancing the country's medicines security, include extending incentives to brownfield expansions and removing restrictions on a change in product mix.
After supply chain vulnerabilities were exposed during the ongoing COVID-19 pandemic, Indian Prime Minister Narendra Modi’s call for an “Atmanirbhar Bharat” or self-reliant India has been finding more resonance.
Though the idea of “Make In India” has been a recurring theme in his government’s policy-making and public statements, an...